Medicare Enrolled
Dr. Farshad Shafizadeh, M.D.
Pathology - Anatomic · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shafizadeh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shafizadeh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shafizadeh
Dr. Farshad Shafizadeh is a pathology - anatomic specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shafizadeh performed 1,753 Medicare services across 1,241 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shafizadeh received a total of $5,051 from 38 pharmaceutical and/or device companies across 139 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pathology - anatomic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shafizadeh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 30% volume in NY
$5,051 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,753
Medicare services
Top 30% in NY for pathology - anatomic
1,241
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~92 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
415 | $73 | $266 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
178 | $10 | $74 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
162 | $11 | $114 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
119 | $109 | $400 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
93 | $0 | $83 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
87 | $8 | $14 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
53 | $223 | $714 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
48 | $93 | $401 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
48 | $99 | $392 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
48 | $30 | $375 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
41 | $2 | $15 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
38 | $330 | $1,193 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
38 | $180 | $729 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $140 | $607 |
| Special tissue stain, multiplex A laboratory procedure using special stains to examine tissue samples. This multiplex technique allows for the analysis of multiple markers on a single slide. |
35 | $33 | $608 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
34 | $24 | $237 |
| Manual microscopic genetic analysis of tumor A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes. |
34 | $35 | $488 |
| Computer-assisted urine cell examination A laboratory test that uses computer technology to analyze cells found in a urine sample. |
33 | $40 | $1,939 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
33 | $92 | $404 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
32 | $30 | $741 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
24 | $128 | $342 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $48 | $169 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
22 | $72 | $273 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
19 | $72 | $310 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
16 | $142 | $1,688 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
15 | $60 | $246 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $118 | $522 |
| Prostate needle biopsy with image guidance A procedure to remove small tissue samples from the prostate gland using a needle. Image guidance is used to help the doctor accurately locate the area for sampling. |
12 | $342 | $1,315 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
23.9% medium
75.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,051
Total received (2018-2024)
Avg $722/year across 7 years
Top 8% in NY for pathology - anatomic
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
139
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,033 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$822
2023
$664
2022
$1,131
2021
$328
2020
$230
2019
$652
2018
$1,225
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
COLOPLAST CORP
$268
Teleflex LLC
$208
AngioDynamics, Inc.
$174
Endo USA, Inc.
$70
Antares Pharma, Inc.
$50
Tolmar, Inc.
$29
Endo Pharmaceuticals Inc.
$22
Top 3 companies account for 79.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,108
BOSTON SCIENTIFIC CORPORATION
$742
Endo Pharmaceuticals Inc.
$500
Teleflex LLC
$354
Astellas Pharma US Inc
$318
COLOPLAST CORP
$268
Medtronic, Inc.
$221
AngioDynamics, Inc.
$174
Medtronic USA, Inc.
$149
FEMSelect Inc.
$139
Clinical Laserthermia Systems Americas Inc.
$127
Caldera Medical, Inc
$88
MEDIVATION FIELD SOLUTIONS LLC
$75
Blue Earth Diagnostics Limited
$71
Endo USA, Inc.
$70
Janssen Biotech, Inc.
$55
Antares Pharma, Inc.
$50
Axonics Modulation Technologies, Inc.
$48
PFIZER INC.
$39
180 Medical, Inc.
$38
AstraZeneca Pharmaceuticals LP
$37
Allergan Inc.
$35
Allergan, Inc.
$34
Myriad Genetic Laboratories, Inc.
$29
Tolmar, Inc.
$29
ABBVIE INC.
$28
DENTSPLY IH AB
$24
Myovant Sciences Inc.
$24
GlaxoSmithKline, LLC.
$24
Bayer HealthCare Pharmaceuticals Inc.
$20
AbbVie Inc.
$19
Clarus Therapeutics Inc.
$19
KARL STORZ Endoscopy-America
$19
Coloplast Corp
$18
Amgen Inc.
$15
Janssen Pharmaceuticals, Inc
$15
TOLMAR Pharmaceuticals, Inc.
$14
Avadel Specialty Pharmaceuticals, LLC
$13
Top 3 companies account for 46.5% of all-time payments
Associated products mentioned in payments ›
ALTIS · AMS · AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · ANORO · AVEED · Axonics r-SNM System · Axumin · BOTOX · BOTOX - UROLOGY · Corlanor · Desara · ELIGARD · ENPLACE · Erleada · GENERAL KIDNEY STONE DISEASE · GENERAL KIDNEY STONE DISEASE · General - Erectile Dysfunction · General - Male SUI · INTERSTIM · JATENZO · LASER APPLICATOR NON-COOLED · LUPRON DEPOT · LYNPARZA · LoFric · MYRBETRIQ · Myrbetriq · NANOKNIFE · Noctiva · Nubeqa · ORGOVYX · Prolaris · Rezum Generator · TOVIAZ · Titan · UROLIFT · UroLift System · VESICARE · XIAFLEX · XTANDI · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for pathology - anatomic in NY.
Geographic Context
Pathology - anatomics within 10 mi
600
Per 100K population
36.9
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shafizadeh is a clinical cardiology specialist, with above-average Medicare volume (top 30% in NY), with low-engagement industry engagement in the top 8% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shafizadeh experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Shafizadeh performed 415 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shafizadeh receive payments from pharmaceutical companies?
Yes. Dr. Shafizadeh received a total of $5,051 from 38 companies across 139 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shafizadeh's costs compare to other pathology - anatomics in New York?
Dr. Shafizadeh's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shafizadeh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pathology - Anatomics in New York
Browse pathology - anatomics in New York ranked by procedure volume and transparency data.
Highest volume
Top Pathology - Anatomics in NY
Pathology - anatomics ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pathology - Anatomics in NY
Which NY pathology - anatomics receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology